High Density Lipoprotein Promoting Proliferation and Migration of Type II Alveolar Epithelial Cells During Inflammation State
Overview
Endocrinology
Authors
Affiliations
Background: To investigate the effect and mechanism of high density lipoprotein (HDL) on type II alveolar epithelial cells during inflammation state.
Methods: The original generation of type II alveolar epithelial cells were separated in rats and treated with PBS/LPS/HDL/HDL + LPS. To observe the proliferation and migration of type II alveolar epithelial cells with bromodeoxyuridine(BrdU) assay, transwell assay and wound healing experiments. In addition, western blot detected the expression of TP-binding cassette transporter A1 (ABCA1), cystic fibrosis transmembrane conductance regulator (CFTR) and the phosphorylation of AKT/extracellular signal-regulated kinase(ERK)/mitogen-activated protein kinase(MAPK). Enzyme-linked immunosorbent assay (ELISA) tested the secretion of tumor necrosis factor a(TNF-a)/interleukin 1a(IL-1a)/IL-6.
Results: HDL promoted the proliferation (↑17%, p < 0.001 HDL+ LPS vs. LPS) and migration (wounding healing: ↑93%, p < 0.001 HDL+ LPS vs. LPS; transwell migration: ↑154%, p < 0.001 HDL+ LPS vs. LPS) of type II alveolar epithelial cells. Furthermore, HDL increased the phosphorylation of MAPK, but not AKT/ERK. And HDL decreased the secretion of TNF-a (↓46%, p < 0.01 HDL+ LPS vs. LPS) and IL-1a (↓45%, p < 0.001 HDL+ LPS vs. LPS), but not IL-6. In addition, HDL up-regulated the expression of ABCAI (↑99%, p < 0.001 HDL vs. CON) and down-regulated the expression of CFTR (↓25%, p < 0.05 HDL vs. CON) in type II alveolar epithelial cells.
Conclusions: HDL increases the phosphorylation of MAPK, which promotes the proliferation and migration of type II alveolar epithelial cells. And it decreased the secretion of TNF-a/IL-1a and the expression of CFTR. All these suggest that HDL plays an important role in anti-inflammatory effect in inflammation state of lung.
Wang Y, Long X, Tan M, Song X Int J Chron Obstruct Pulmon Dis. 2024; 19:2321-2332.
PMID: 39465032 PMC: 11512790. DOI: 10.2147/COPD.S481197.
Wen X, Wu X, Deng Z, Wu F, Yang H, Xiao S Int J Chron Obstruct Pulmon Dis. 2024; 19:1801-1812.
PMID: 39129965 PMC: 11316472. DOI: 10.2147/COPD.S467976.
Novel insights into the potential applications of stem cells in pulmonary hypertension therapy.
Guo S, Wang D Respir Res. 2024; 25(1):237.
PMID: 38849894 PMC: 11162078. DOI: 10.1186/s12931-024-02865-4.
High-Density Lipoproteins: A Role in Inflammation in COPD.
Kotlyarov S Int J Mol Sci. 2022; 23(15).
PMID: 35897703 PMC: 9331387. DOI: 10.3390/ijms23158128.
Extracellular Lipids in the Lung and Their Role in Pulmonary Fibrosis.
Burgy O, Loriod S, Beltramo G, Bonniaud P Cells. 2022; 11(7).
PMID: 35406772 PMC: 8997955. DOI: 10.3390/cells11071209.